Cardlytics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cardlytics, Inc. on December 5, 2025, reporting an event that occurred on December 3, 2025. The filing addresses a significant change in the company's executive leadership.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes rather than financial performance data.
Material Changes
The primary material change reported is the resignation of Alexis DeSieno, the Company's Chief Financial Officer. Her resignation is effective as of the earlier of the appointment of her successor or the close of business on March 6, 2026. The Company has initiated a search for a replacement.
Management Commentary and Risks
- Reason for Departure: Ms. DeSieno's resignation is not the result of any disagreement with the Company regarding operations, policies, practices, financial statements, or internal controls.
- Transition Plan: If a successor is appointed before March 6, 2026, Ms. DeSieno will remain in a non-officer advisory role through that date to facilitate the transition of responsibilities.
- Compensation: She will continue to receive her current base salary and benefits until her employment ends.
- Management Acknowledgement: The Company thanked Ms. DeSieno for her efforts in improving the balance sheet, liquidity, and optimizing the cost structure.
Investor Verification Checklist
- Confirm the timeline for the appointment of a new Chief Financial Officer.
- Monitor subsequent filings for the identity of the successor and any changes to the transition plan.
- Review upcoming quarterly reports to assess the impact of the CFO transition on financial reporting and internal controls.
- Verify if the "improvement of balance sheet and liquidity" mentioned in the departure notice is reflected in the most recent 10-Q or 10-K filings.